Dashboard
Manage Tickers

DRIODarioHealth Corp.

Nasdaq mydario.com


$ 1.75 $ -0.02 (-1.14 %)    

Tuesday, 14-May-2024 15:59:52 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 1.73
$ 1.81
$ 0.00 x 0
$ 0.00 x 0
$ 1.72 - $ 1.83
$ 0.68 - $ 4.58
268,694
na
49.08M
$ 1.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-21-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-09-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 05-12-2020 03-31-2020 10-Q
18 03-17-2020 12-31-2019 10-K
19 10-28-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-13-2019 03-31-2019 10-Q
22 03-25-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 03-19-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 03-22-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-11-2016 03-31-2016 10-Q
34 02-08-2016 12-31-2015 10-K
35 11-13-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-24-2015 12-31-2014 10-K
39 11-14-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

dariohealth-q1-net-loss-72m-compared-to-128m-yoy
DarioHealth Q1 Net Loss $(7.2)M Compared T...
05/15/2024 10:34:37

dariohealth-q1-sales-5758m-miss-6758m-estimate
DarioHealth Q1 Sales $5.758M Miss $6.758M ...
05/15/2024 10:32:58

DarioHealth (NASDAQ:DRIO) reported quarterly sales of $5.758 million which missed the analyst consensus estimate of $6.758 mill...

dario-publishes-new-peer-reviewed-study-that-deepens-the-body-of-evidence-that-managing-cardiometabolic-conditions-in-one-integrated-platform-improves-clinical-outcomes
Dario Publishes New Peer-Reviewed Study Th...
04/25/2024 12:47:01

Quasi-randomized study demonstrates the value of Dario's integrated approach to provide one solution for members to manage ...

dario-signs-two-employers-for-cardiometabolic-suite-with-integrated-glp-1-solution-beginning-in-q2-of-2024
Dario Signs Two Employers For Cardiometabo...
04/18/2024 12:34:17

Dario selected to provide integrated and proven solutions to improve employee cardiometabolic healthNEW YORK, April 18, 2024 /P...

dario-publishes-two-peer-reviewed-studies-demonstrating-impact-of-digital-behavioral-health
Dario Publishes Two Peer-Reviewed Studies ...
04/10/2024 12:34:41

Studies include a Randomized Controlled Trial demonstrating significant reduction in perceived stress for teens

two-national-employers-select-darios-integrated-chronic-condition-solution-to-improve-employee-health
Two National Employers Select Dario's Inte...
04/02/2024 12:40:18

DarioHealth Corp. (NASDAQ:DRIO) ("Dario" or the "Company"), a leader in the global digital health market, annou...

stifel-maintains-buy-on-dariohealth-maintains-4-price-target
Stifel Maintains Buy on DarioHealth, Maint...
04/01/2024 15:01:39

Stifel analyst David Grossman maintains DarioHealth (NASDAQ:DRIO) with a Buy and maintains $4 price target.

dariohealth-q4-eps-041-beats-054-estimate
DarioHealth Q4 EPS $(0.41) Beats $(0.54) E...
03/28/2024 10:43:02

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.54) b...

dariohealth-q4-sales-362m-beat-357m-estimate
DarioHealth Q4 Sales $3.62M Beat $3.57M Es...
03/28/2024 10:35:24

DarioHealth (NASDAQ:DRIO) reported quarterly sales of $3.62 million which beat the analyst consensus estimate of $3.57 million ...

earnings-scheduled-for-march-28-2024
Earnings Scheduled For March 28, 2024
03/28/2024 09:24:44

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

earnings-outlook-for-dariohealth
Earnings Outlook For DarioHealth
03/27/2024 17:00:55

new-research-from-dario-demonstrates-ability-to-deliver-improved-health-outcomes-with-integrated-solution-for-members-managing-weight-and-blood-glucose-with-or-without-glp-1-medications
New Research From Dario Demonstrates Abili...
03/12/2024 12:49:55

Study presented at ATTD 2024 is the first of a planned series examining the impact of Dario's integrated cardiometabolic so...

concurrent-to-twill-acquisition-deal-dariohealth-priced-224m-equity-financing
Concurrent To Twill Acquisition Deal, Dari...
02/21/2024 11:05:58

Dario priced a $22.4 million private placement of convertible preferred stock, priced at the market under Nasdaq rules, with pa...

dariohealth-has-acquired-twill-to-create-comprehensive-digital-offerings-for-chronic-conditions-dario-paid-10m-in-cash-and-agreed-to-issue-approximately-10m-shares-in-the-form-of-pre-funded-warrants
Dariohealth Has Acquired Twill, To Create ...
02/21/2024 11:04:15

Expecting nearly doubling Dario's pro forma revenues in 2023 Acquisition is immediately accretive to revenue and gross mar...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
01/12/2024 13:05:59

darios-cardiometabolic-announces-contract-to-provide-cardiometabolic-solutions-to-regional-union-financial-terms-not-disclosed
Dario's Cardiometabolic Announces Contract...
01/11/2024 13:33:20

Dario's integrated solution to support improved whole health gains traction in public and labor market

national-employer-selects-dario-cardiometabolic-and-glp-1-solutions-to-improve-employee-health
National Employer Selects Dario Cardiometa...
12/05/2023 13:40:54

New client will use Dario's integrated approach to support long-term behavior change for employees living with diabetes, pr...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
12/05/2023 13:07:35

dario-contracts-with-new-employer-for-cardiometabolic-solution-beginning-in-january-2024
Dario Contracts With New Employer For Card...
11/27/2023 13:38:49

Demand for Dario's integrated cardiometabolic solution continues to grow as employers grappling with the surge in GLP-1 med...

dario-publishes-new-research-demonstrating-that-dario-users-that-increased-physical-activity-can-maintain-reduced-blood-glucose
Dario Publishes New Research Demonstrating...
11/13/2023 13:55:06

New study highlights the value of a whole health approach managing chronic conditions and supporting members using GLP-1sNEW YO...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION